Latha Vairavan
Chief Financial Officer, Arcutis Biotherapeutics, Inc.
Companies
- Arcutis Biotherapeutics, Inc.Chief financial officer May 7, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Arcutis Biotherapeutics, Inc. ARQT85,978 shares2$2.8M at $32.50May 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 11, 2026Sold 435 shares at $21.05 of Arcutis Biotherapeutics, Inc.2
- May 4, 2026Sold 1,341 shares at $23.61 of Arcutis Biotherapeutics, Inc.3
- Mar 2, 2026Sold 81 shares at $25.91 of Arcutis Biotherapeutics, Inc.4
- Mar 2, 2026Sold 2,772 shares at $25.16 of Arcutis Biotherapeutics, Inc.4
- Feb 27, 2026Granted 27,000 shares of Arcutis Biotherapeutics, Inc.4
- Feb 2, 2026Sold 1,320 shares at $25.50 of Arcutis Biotherapeutics, Inc.5
- Nov 3, 2025Sold 88 shares at $24.72 of Arcutis Biotherapeutics, Inc.6
- Aug 4, 2025Sold 89 shares at $14.33 of Arcutis Biotherapeutics, Inc.7
- May 6, 2025Granted 20,000 shares of Arcutis Biotherapeutics, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed May 6, 2026
- 4SEC EDGARForm 4 filed Mar 3, 2026
- 5SEC EDGARForm 4 filed Feb 4, 2026
- 6SEC EDGARForm 4 filed Nov 5, 2025
- 7SEC EDGARForm 4 filed Aug 5, 2025
- 8SEC EDGARForm 4 filed May 7, 2025